A detailed history of New Century Financial Group, LLC transactions in Argenx Se stock. As of the latest transaction made, New Century Financial Group, LLC holds 512 shares of ARGX stock, worth $319,395. This represents 0.1% of its overall portfolio holdings.

Number of Shares
512
Previous 556 7.91%
Holding current value
$319,395
Previous $239 Million 16.07%
% of portfolio
0.1%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$434.22 - $551.9 $19,105 - $24,283
-44 Reduced 7.91%
512 $278 Million
Q2 2024

Aug 27, 2024

SELL
$356.01 - $451.55 $19,224 - $24,383
-54 Reduced 8.85%
556 $239 Million
Q1 2024

Apr 19, 2024

BUY
$356.95 - $413.29 $18,918 - $21,904
53 Added 9.52%
610 $240 Million
Q4 2023

Feb 08, 2024

BUY
$338.91 - $506.01 $188,772 - $281,847
557 New
557 $212 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.5B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track New Century Financial Group, LLC Portfolio

Follow New Century Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Century Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Century Financial Group, LLC with notifications on news.